Literature DB >> 16603513

Epstein-Barr virus origin of lytic replication mediates association of replicating episomes with promyelocytic leukaemia protein nuclear bodies and replication compartments.

Wolfgang Amon1, Robert E White, Paul J Farrell.   

Abstract

Epstein-Barr virus (EBV) establishes a latent persistence from which it can be reactivated to undergo lytic replication. Late lytic-cycle gene expression is linked to lytic DNA replication, as it is sensitive to the same inhibitors that block lytic replication, and it has recently been shown that the viral origin of lytic replication (ori lyt) is required in cis for late-gene expression. During the lytic cycle, the viral genome forms replication compartments, which are usually adjacent to promyelocytic leukaemia protein (PML) nuclear bodies. A tetracycline repressor DNA-binding domain-enhanced green fluorescent protein fusion was used to visualize replicating plasmids carrying a tetracycline operator sequence array. ori lyt mediated the production of plasmid replication compartments that were associated with PML nuclear bodies. Plasmids carrying ori lyt and EBV itself were visualized in the same cells and replicated in similar regions of the nucleus, further supporting the validity of the plasmids for studying late-gene regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603513     DOI: 10.1099/vir.0.81589-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Live visualization of herpes simplex virus type 1 compartment dynamics.

Authors:  Anna Paula de Oliveira; Daniel L Glauser; Andrea S Laimbacher; Regina Strasser; Elisabeth M Schraner; Peter Wild; Urs Ziegler; Xandra O Breakefield; Mathias Ackermann; Cornel Fraefel
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

2.  Interaction of Kaposi's sarcoma-associated herpesvirus ORF6 protein with single-stranded DNA.

Authors:  Sezgin Ozgur; Jack Griffith
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

3.  The Kaposi's sarcoma-associated herpesvirus ORF6 DNA binding protein forms long DNA-free helical protein filaments.

Authors:  Sezgin Ozgur; Blossom Damania; Jack Griffith
Journal:  J Struct Biol       Date:  2010-10-31       Impact factor: 2.867

4.  Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.

Authors:  Wen-Hung Wang; Chung-Wen Kuo; Li-Kwan Chang; Chen-Chia Hung; Tzu-Hsuan Chang; Shih-Tung Liu
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

5.  Genome-wide analysis of Epstein-Barr virus Rta DNA binding.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Daniel Portal; Yong Lu; Eric Johannsen
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

6.  Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition.

Authors:  Ya-Fang Chiu; Arthur U Sugden; Bill Sugden
Journal:  Cell Host Microbe       Date:  2013-12-11       Impact factor: 21.023

7.  Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.

Authors:  Nina Tavalai; Thomas Stamminger
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

8.  Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.

Authors:  Yoshihiro Izumiya; Keisuke Kobayashi; Kevin Y Kim; Mamata Pochampalli; Chie Izumiya; Bogdan Shevchenko; Don-Hong Wang; Steve B Huerta; Anthony Martinez; Mel Campbell; Hsing-Jien Kung
Journal:  PLoS Pathog       Date:  2013-08-22       Impact factor: 6.823

9.  Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells.

Authors:  Qinyan Yin; Mark Sides; Christopher H Parsons; Erik K Flemington; Joseph A Lasky
Journal:  Virol J       Date:  2017-06-21       Impact factor: 4.099

10.  An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription.

Authors:  Reza Djavadian; Ya-Fang Chiu; Eric Johannsen
Journal:  PLoS Pathog       Date:  2016-06-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.